Dengvaxia, approved by the FDA, is for individuals 9-16 in dengue-endemic areas. Controversy arose due to differing vaccine performance in those with and without previous dengue infection. The vaccine can lead to severe dengue in seronegative individuals and was misused in the Philippines, causing a vaccine hesitancy crisis. It’s only necessary if living in endemic areas.
Dengvaxia for Dengue Fever Read More »
So we know that we need a better pertussis vaccine. DTaP and Tdap just aren’t doing the job that they should be doing. So when will we get one? Making a Better Pertussis Vaccine Since anti-vaccine folks are always talking about the 300 new vaccines in the pipeline, you would think that we would have
Making a Better Pertussis Vaccine Read More »
Why is there a shortage of Shingrix, the new shingles vaccine?
The Shingles Vaccine Shortage Read More »
What’s the difference between Tdap and DTaP?
Are the Tdap and DTaP Vaccines the Same Thing? Read More »
You must be logged in to post a comment.